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Abstract Coronary transient receptor potential canonical
(TRPC) channel expression is elevated in metabolic syn-
drome (MetS). However, differential contribution of
TRPCs to coronary pathology in MetS is not fully eluci-
dated. We investigated the roles of TRPC1 and TRPC6
isoforms in coronary arteries of MetS pigs and determined
whether long-term treatment with a mineralocorticoid
receptor inhibitor, spironolactone, attenuates coronary
TRPC expression and associated dysfunctions. MetS
coronary arteries exhibited significant atherosclerosis,
endothelial dysfunction, and increased histamine-induced
contractions. Immunohistochemical studies revealed that
TRPC6 immunostaining was significantly greater in the
medial layer of MetS pig coronary arteries compared to
that in Lean pigs, whereas little TRPC6 immunostaining
was found in atheromas. Conversely, TRPC1 immunos-
taining was weak in the medial layer but strong in MetS
atheromas, where it was predominantly localized to mac-
rophages. Spironolactone treatment significantly decreased
coronary TRPC expression and dysfunctions in MetS pigs.
In vivo targeted delivery of the dominant-negative (DN)-
TRPC6 cDNA to the coronary wall reduced histamine-in-
duced calcium transients in the MetS coronary artery
medial layer, implying a role for TRPC6 in mediating
calcium influx in MetS coronary smooth muscles. Mono-
cyte adhesion was increased in Lean pig coronary arteries
cultured in the presence of aldosterone; and spironolactone
antagonized this effect, suggesting that coronary miner-
alocorticoid receptor activation may regulate macrophage
infiltration. TRPC1 expression in atheroma macrophages
was associated with advanced atherosclerosis, whereas
medial TRPC6 upregulation correlated with increased
histamine-induced calcium transients and coronary con-
tractility. We propose that long-term spironolactone treat-
ment may be a therapeutic strategy to decrease TRPC
expression and coronary pathology associated with MetS.
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Introduction
Metabolic syndrome (MetS) is a condition characterized by
central obesity, insulin resistance, glucose intolerance,
dyslipidemia, hypertension, and atherosclerosis
[23, 38, 50]. Atherosclerosis usually occurs in the large and
medium-sized arteries [19]. Atherosclerotic plaques are
made of lipids, cholesterol, extracellular matrix deposits,
proliferating smooth muscle cells (SMCs), T-lymphocytes,
foam cells, and macrophages. These lesions decrease the
vessel lumen area and cause obstruction of blood flow.
Wennan Li and Xingjuan Chen equally contributed to this work.
Electronic supplementary material The online version of this
article (doi:10.1007/s00395-017-0643-0) contains supplementary
material, which is available to authorized users.
& Alexander G. Obukhov
aobukhov@iu.edu
1 Department of Cellular and Integrative Physiology, Indiana
University School of Medicine, Indianapolis, 635 Barnhill
Dr., MS360A, Indianapolis, IN 46202, USA
2 Indiana University Pathology, Immunohistochemistry Core,
Indiana University School of Medicine, Indianapolis,
Indianapolis, IN, USA
3 Department of Anesthesia, Indiana University School of
Medicine, Indianapolis, Indianapolis, IN, USA
4 Department of Ophthalmology, Indiana University School of
Medicine, Indianapolis, Indianapolis, IN, USA
123
Basic Res Cardiol (2017) 112:54
DOI 10.1007/s00395-017-0643-0
Furthermore, atherosclerotic coronary arteries exhibit
increased spasticity [46, 49] that may lead to angina,
myocardial infarction, and sudden death [27].
Angina patients present with elevated plasma his-
tamine concentration [43], indicating that histamine-in-
duced coronary artery contractions may contribute to
some ischemic episodes in these patients. Indeed, his-
tamine is known to contract coronary arteries, with the
presence of atherosclerosis potentiating the contractile
response [11, 22]. In the coronary circulation, histamine
mainly originates from mast cells infiltrating atheroscle-
rotic lesions [47]; and mast cells are often found at the
site of coronary spasm in the patients with angina [18].
In turn, histamine is an activator of transient receptor
potential canonical (TRPC) calcium-permeable cation
channels [10, 12, 41], which are expressed in vascular
SMCs. TRPC channels are implicated in the pathogene-
sis of hypertension and neointimal hyperplasia
[1, 33, 40].
One of the features of MetS is elevated plasma aldos-
terone [6, 13, 32]. Aldosterone is an agonist of the miner-
alocorticoid receptor, which is widely expressed in the
kidney, heart, and vasculature [29, 37]. Elevated aldosterone
may induce extracellular matrix remodeling by enhancing
collagen synthesis, fibrosis, and vascular inflammation
[5, 36] and is considered a risk factor for heart failure,
myocardial infarction, stroke, and coronary artery disease
[25, 28, 35]. Indeed, both human and animal studies have
shown that aldosterone may be involved in facilitating
atherosclerosis development [15, 20, 25, 31, 37].
Our previous study showed that TRPC1 and TRPC6
expression is increased in coronary arteries from MetS pigs
as compared to Lean pigs [16]. We also reported that
aldosterone, acting via the mineralocorticoid receptor,
increased TRPC1 and TRPC6 expression in the adrenal
medulla of MetS pigs [26] exhibiting elevated plasma
aldosterone [2]. Consistently, Bae et al. reported that
mineralocorticoids enhance TRPC6 expression in rat aortic
smooth muscle cells [3]. In this study, we investigated the
roles of TRPC1 and TRPC6 channels in the coronary artery
of MetS pigs and whether long-term inhibition of the
mineralocorticoid receptor by spironolactone downregu-




Thirty-six castrated Ossabaw miniature pigs were subdi-
vided into three groups: Lean, metabolic syndrome (MetS),
and metabolic syndrome treated with spironolactone
(MetS-SN). The pigs were initially fed with the standard
chow consisting of 22% kcal from protein, 70% kcal from
carbohydrates, and 8% kcal from fat (5L80 diet, Purina
Test Diet, Richmond, IN, USA) until an age of
6–8 months. Then, the Lean group of pigs was maintained
on the same standard chow for an additional 7–9 months.
The MetS group of pigs was fed with an atherogenic diet,
consisting of 16% kcal from protein, 21% kcal from mixed
carbohydrates, 20% kcal from fructose, and 43% kcal from
fat, which was supplemented with 2% cholesterol and 0.7%
sodium cholate by weight (KT324 diet, Purina Test Diet,
Richmond, IN, USA; 1 kg/day) for 7–9 months, similar to
previous reports [16]. The pigs from the MetS-SN group
were fed the atherogenic KT324 diet (1 kg/day) mixed
with spironolactone (3 mg/kg body weight/day). During
this study, two out of 13 investigated MetS pigs prema-
turely died. Postmortem histological assessment indicated
that these two pigs had very advanced atherosclerosis,
suggesting that the pigs had likely died due to a myocardial
infarction. In contrast, no deaths occurred in the Lean (14
pigs) or MetS-SN (9 pigs) groups.
Intravenous glucose tolerance test (IVGTT)
Prior to the test, pigs were acclimated to a canvas sling,
which was used to suspend a pig above the ground, for
30–60 min daily for 3–5 days. A day before an IVGTT, the
central venous catheter (Cook Medical, Bloomington, IN,
USA) was percutaneously placed into the jugular vein
under isoflurane anesthesia and secured on the lateral side
of the neck for future blood sampling. All pigs were fasted
overnight before IVGTTs, and the tests were performed
without anesthesia because it artificially elevates blood
glucose concentration. A single dose of 1 g glucose/kg
body weight was given at a time of zero through the central
venous catheter. Then, *3 ml blood samples were col-
lected every 10 min for 60 min via the same catheter to
assess glucose tolerance. Blood samples were centrifuged
at 2000 rpm for 20 min at 4 C to collect blood serum;
serum glucose concentration was determined using an YSI
2300 STAT plus Glucose analyzer (YSI Life Sciences.,
Yellow Springs, OH, USA).
Intravascular ultrasound (IVUS)
Ceftiofur (5 mg/kg, IM) and aspirin (300 mg) were given
to pigs on the day of the procedure. Anesthesia induction
was carried out using an intramuscular injection of a
mixture of telazol (5 mg/kg) and xylazine (3 mg/kg) that
was followed by isoflurane endotracheally (2–4% mixed
with 100% O2) to maintain anesthesia. The anesthetized,
heparinized, and intubated unconscious animal was secured
in a supine position, and a subcutaneous injection of a
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mixture of topical anesthetics (2% lidocaine and 2%
bupivacaine; 50:50) was given before the surgery. The
arterial sheath introducer (7 F introducer sheath, Boston
Scientific, Marlborough, MA, USA) was placed into the
right femoral artery through an arteriotomy. Using X-ray
angiography to monitor the progress of placements, the
guiding catheter (7 F guide catheter, Mach1, HS SH,
AL.75 SH, Boston Scientific) engaged the coronary ostium
and then an angioplasty guidewire was deployed into a
coronary artery. A contrast solution injection (OMNIPA-
QUE, GE healthcare, Princeton, NJ, USA) was used to
visualize the coronary artery tree. Then, the Revolution
45 MHz Rotational Imaging Intravascular Ultrasound
Catheter-transducer (Volcano Inc, Rancho Cordova, CA,
USA) was advanced along the guide wire to the distal part
of the coronary artery and the pullback of the IVUS
transducer was performed at 0.5 mm/s. Cross-sectional
IVUS images were acquired every 2 mm through the
*40 mm length of coronary arteries. The plaque wall
coverage was measured using the Image-Pro Premier 9.1
software package (Media Cybernetics Inc., Warrendale,
PA, USA) to determine the extent of atherosclerosis. Per-
cent wall coverage (% wall coverage) was calculated as the
length of plaque-covered coronary artery wall segment
divided by the coronary artery perimeter and multiplied by
100. The wall coverage data from 20 images for each
individual right coronary artery (RCA) and left anterior
descending (LAD) coronary artery of a pig were averaged
to represent the mean wall coverage value for the pig. Then
the mean wall coverage for each treatment group was
calculated by averaging the mean wall coverage data
obtained in each pig.
Masson’s trichrome staining
and immunohistochemistry
Freshly isolated coronary arteries were cut into 3 mm
cross-sectioned rings, fixed in 10% phosphate-buffered
formalin (Fisher Scientific, Fair Lawn, NJ, USA), and then
embedded in paraffin. Paraffin blocks were cut into 5 lm
thick sections, which were de-paraffinized and rehydrated
after mounting on glass slides. Masson’s trichrome staining
was performed using the DAKO Masson’s Trichrome Stain
kit on the ArtisanTM Link Special Stains Instrument (Dako
North America, Inc., Agilent Technologies, Carpinteria,
CA, USA). Collagen in the coronary wall stained blue and
SMCs stained red. Collagen content measurements were
performed within the entire medial layer and atheroma.
Hematoxylin and eosin (H&E) staining was performed
using the H&E Staining Kits from Tissue-Tek Prisma
Automated Slide Stainers. Sections were examined using a
Nikon microscope. Images were taken randomly from at
least four different areas of the ring at 49 or 209
magnification. Image-Pro was used to quantify the positive
staining. Results were expressed as a percentage of blue
collagen staining over total area in the medial layer or the
atheroma.
Immunostaining was performed using the following
antibodies: the a-smooth muscle actin antibody (dilution
1:50, a-SMA, human, Sigma, St. Louis, MO, USA), the
TRPC1 antibody (dilution 1:50, gift from Dr. Tsiokas), the
TPRC6 antibody (dilution 1:25, S-20, Santa Cruz
Biotechnology, Dallas, TX, USA), the CD163 antibody
(1:100, Vector, Burlingham, CA, USA), the CD4 antibody
(ready-to-use, IR649, DAKO, Glostrup, Denmark), and the
CD33 antibody (ready-to-use, PWS44, Cell Marque,
Rocklin, CA, USA). After incubations with the primary
antibodies at room temperature, the sections were then
probed using the DAKO Flex system (SMA, CD163, and
CD4), the DAKO Omnis (CD33), the DAKO Envi-
sion ? mouse (TRPC1) or with the secondary biotin
AffiniPure donkey anti-goat antibody for TRPC6 (dilution
factor 1:100, The Jackson ImmunoResearch Laboratory,
West Grove, PA, USA), followed by the DAKO LSAB2
horseradish peroxidase-conjugated polymer. All washes
were made using the DAKO wash buffer. The brown color
was developed using diaminobenzidine. The staining den-
sity was quantified using the DAB analysis module of
Image-Pro Premier 9.1 (Media Cybernetics Inc., Warren-
dale, PA, USA). The specific staining is reported after
normalization to adventitia background staining density.
In vivo gene delivery
A micro-infusion Bullfrog catheter [21] (Mercator
Medsystems, San Leandro, CA, USA) was used to deliver
the cDNA into the coronary artery wall and a custom made
intravascular electroporation catheter [45] (Cardigant
Medical Inc., Manhattan Beach, CA, USA) to transiently
electropermeabilize SMCs, allowing their loading with
cDNA. Since both catheters were designed for 3 mm
arteries, before performing an in vivo gene delivery pro-
cedure, a coronary artery segment of 3 mm diameter was
identified using IVUS. The segment chosen was a site that
was close to a prominent coronary artery branch. This
allowed identification of the segment following dissec-
tion. After completing the IVUS procedure, the IVUS
catheter was withdrawn from the coronary artery and the
micro-infusion Bullfrog catheter was advanced into the
same artery under angiographic guidance to the selected
artery segment. The 130 lm diameter injecting needle was
deployed into the coronary vascular wall, and an injection
of 0.7–1 ml of 1 mg/ml dominant-negative (DN) pig
TRPC6 (L645A/F646A/W647A) cDNA in the pcDNA3.1
vector or the empty vector in sterile NaCl solution was
performed. The needle was retracted and the injection
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catheter was withdrawn. The intravascular electroporation
catheter was deployed to the site of injection and in vivo
electroporation was performed using three square 20 ms
voltage pulses of 75 V with an interval of 1 s. After the
intra-coronary intervention was completed, the catheters
and the guide wire were withdrawn and the incision was
sutured. Aspirin (300 mg) was given to the pig by mouth
with the feed a day before and a day after surgery. The
expression of DN-TRPC6 was driven with the human
cytomegalovirus immediate-early promoter of the
pcDNA3.1 vector. The in vivo electroporated pigs were
euthanized 48 h after the in vivo cDNA delivery procedure.
Isometric tension measurement
Isolated coronary arteries were cut into 2–3 mm rings and
mounted in the organ baths containing Krebs solution
saturated with a gas mixture of 95% O2 and 5% CO2 at
37 C. The optimal length was determined as described
elsewhere [8, 11, 24]. This usually resulted in a preload
value of *3 g. Both KCl and histamine were added
directly to the organ baths. The standard Krebs buffer
contained (mM): 131.5 NaCl, 5 KCl, 2.5 CaCl2, 1.2
NaH2PO4, 1.2 MgCl2, 25 NaHCO3, and 10 glucose. Vessel
tensions were measured using a GlobalTown Microtech-
nology (Sarasota, FL, USA) wire myograph. Active tension
was determined as the difference of the peak and baseline
tension.
Front-surface fluorometry in coronary artery rings
A monochromator-equipped imaging system (TILL-Pho-
tonics, Martinsreid, Germany) was used to monitor intra-
cellular Ca2? changes in coronary artery rings. Cross-
sectioned rings (*1 mm thick) were loaded with fura-2 by
incubating with 8 lM fura-2AM (Molecular Probes, Inc.,
Eugene, OR, USA) for 6–10 h in a phosphate-buffered
saline (DPBS, Cat # 14287, ThermoFisher Scientific,
Waltham, MA, USA) solution containing 0.9 mM Ca2?,
0.49 Mg2?, supplemented with 5.55 mM D-glucose,
0.33 mM sodium pyruvate, and 2% bovine serum albumin
(BSA), at room temperature in the dark. Rings were
washed three times with PBS without fura-2AM and
incubated in solutions without fluorescent dye for addi-
tional 30–60 min at room temperature. Fura-2 fluorescence
was induced by alternating excitation at 345 and 380 nm.
The obtained data were analyzed using TILLvisION soft-
ware. The background fluorescence measured in a ring free
area was subtracted from all fluorescence values before the
determination of the F345/F380 ratio. The peak amplitudes
of KCl and histamine were determined by subtracting the
baseline ratio. The histamine steady state amplitude values
were measured at the time point of 3.3 min after the
histamine response peaked. The standard extracellular
solution for fluorescence measurements contained (mM):
140 NaCl, 2.5 KCl, 1 MgCl2, 5 CaCl2, 4 glucose, 10
HEPES (pH 7.2).
Preparation of porcine peripheral blood
mononuclear cells (PBMCs) and enrichment
of monocytes
Porcine blood was collected in sodium heparin-containing
tubes and immediately used for PBMC isolation with
Ficoll-Paque PLUS (GE Healthcare Bio-Sciences, PA,
USA) according to instructions by the manufacturer. 10
million PBMCs cells were stained with PerCPCy5.5 Anti-
Pig CD3e (12 mg/ml, clone: BB23-8E6-8c8, BD
Pharmingen) and R-phycoerythrin Anti-Pig CD79a (8 mg/
ml, clone: HM47, eBioscience) antibodies and then sorted
on the BD SORP Aria instrument. The stained PBMCs
were first gated with high Forward Scatter (FSC-A) and
high Side-Scatter (SSC-A) of light to collect monocyte
subpopulations, which were further sorted to exclude the
cells positive for CD3e and CD79a. Enrichment was
assessed by staining the initial PBMC samples and sorted
monocyte samples with fluorescein isothiocyanate anti-pig
monocyte/granulocytes CD172a (10 mg/ml, clone
74-2215A, BD Pharmingen) and PerCPCy5.5 anti-pig
CD3e antibodies. The monocyte enrichment was 77–82%
(n = 4).
Coronary artery organ-culture
Lean pig coronary arteries (3 mm long strips or rings) were
pretreated for 2–7 days with either vehicle (DMSO),
aldosterone (100 nM), a mixture of aldosterone and
spironolactone (100 nM and 10 lM, respectively), or
spironolactone (10 lM) in EMEM (cat # 30-2003, ATCC,
Manassas, VA, USA) supplemented with 2% bovine serum
albumin, 50 units penicillin, and 50 lg/ml streptomycin.
The medium was replaced daily. Organ-cultured coronary
artery segments were maintained at 37 C in a water-
jacketed 5% CO2 incubator.
Monocyte adhesion assay
Organ-cultured coronary artery strips were treated with
vehicle (DMSO), aldosterone (100 nM), a mixture of
aldosterone and spironolactone (100 nM and 10 lM,
respectively), or spironolactone (10 lM) for 48 h. The
isolated pig peripheral blood monocytes were loaded with
Carboxy SNARF-1 (10 lM, Spiro[7H-benzo [c]xanthene-
7,10(3H)-isobenzofuran]-ar0-carboxylic acid, 3-(acetyloxy)-
10-(dimethylamino)-30-oxo-, (acetyloxy)methyl ester;
ThermoFisher Scientific) for 30 min at room temperature.
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The SNARF-1 loaded monocytes (3 9 104–2 9 105 cells
per well) were added to the four listed above groups of
treated organ-cultured strips and incubated for 2 h at 37 C
on the stage of a horizontal New Brunswick Scientific
Shaker, rotating at 75 rpm in the atmosphere of 5% CO2
and 95% oxygen. After the incubation period, the strips
were gently washed three times with PBS supplemented
with Ca2?, Mg2?, glucose, and pyruvate (catalog # 14287,
Thermo Fisher Scientific) and then were fixed in 10%
phosphate-buffered formalin. The sections were next
mounted on glass slides with the lumen facing up using
Vectashield Antifade Mounting Medium with 40,6-di-
amidino-2-phenylindole (Catalog #: H-1200, Vector Lab-
oratories, Inc., Burlingame, CA, USA). The fluorescence of
SNARF-1 was excited at 570 nm and the emitted light was
collected with a longpass filter of 600 nm, and the fluo-
rescence of 40,6-diamidino-2-phenylindole (DAPI) was
excited at 360 nm and the emitted light was collected with
a band filter of 400–450 nm. Blue DAPI fluorescence was
used to focus on the endothelium layer of the coronary
strips, and then the red fluorescence of SNARF was used to
identify the attached monocytes. The number of adherent
monocytes was determined using the Till Photonics single-
cell fluorescence imaging system by counting the red flu-
orescing cells attached to the surface of the endothelium.
Each value represents an average of the adherent monocyte
counts observed in three different images for each strip.
Pig macrophage culture and differentiation
Freshly isolated peripheral blood mononuclear cells were
suspended in the macrophage growth medium and were
then plated on plastic 24-well plates (BD Biosciences,
Thermo Fisher Scientific). The macrophage growth med-
ium consisted of RPMI-1640 (Gibco, Thermo Fisher
Scientific), supplemented with 15% L929 conditioned
medium, 15% horse serum, 5% FBS, 1 mM glutamine, 50
units penicillin, and 50 lg/ml streptomycin. Cells were
cultured for 3 days, and on day 3, the old medium and
floating cells were removed from the wells. The attached
cells were washed one time with PBS and then with fresh
macrophage growth medium and cultured further for an
additional 2 days. On day 5, the old macrophage growth
medium was removed leaving 0.5 ml in each well, and
then fresh macrophage growth medium was added to the
wells. On day 7, the differentiated macrophages were
used for total mRNA isolation as described later. The
L929 conditional medium was prepared as follows. L929
cells (ATCC) were grown in complete DMEM supple-
mented with 10% fetal bovine serum, 50 units penicillin,
and 50 lg/ml streptomycin until 90% confluence for four
days. The supernatant was collected in 50 ml centrifuge
tubes, centrifuged at 10,000 g to remove cell debris and
after filtration (20 lm) used as the conditioned L929
medium.
Real-time quantitative PCR (RT-qPCR)
Total RNA from snap-frozen Lean pig coronary artery
rings organ-cultured for 36 h was isolated using the Trizol
method (Invitrogen) with a subsequent deoxyribonuclease
treatment step to eliminate any possible traces of the
genomic DNA in the total RNA. The Bio-Rad iScript
cDNA synthesis kit was utilized to reverse-transcribe
cDNA using total RNAs as templates. Total RNA from
macrophage cultures was isolated using the RNeasy Mini
kit (Qiagen) according to manufacturer’s instructions. The
superscript VILO cDNA synthesis kit was used to reverse-
transcribe cDNA using total RNAs as templates. The
Applied Biosystems (Foster City, CA, USA) 7500 Real-
Time PCR System was utilized to perform RT-qPCR. The
data were quantified using the standard DDCt method. The
endogenous controls (18S ribosomal (r) RNA or b2 micro
globulin) were amplified with TaqMan Universal PCR
Master Mix (Applied Biosystems), whereas TRPC1 and
TRPC6 were amplified using SYBR Green Master mix




(18S rRNA, forward), and 50-GGTCCAAGAATTT
CACCTCT-30 (18S rRNA, reverse). The RT2 qPCR primer
assays for TRPC1 and b2 micro globulin were from QIA-
GEN (Mansfield, MA, USA; Cat.#: PPS03885A and Cat.#
PPS00376A, respectively). The RT2 qPCR primer
sequences were not disclosed by the manufacture. The no-
reverse-transcriptase control was performed and was
negative.
Chemicals
All inorganic salts and buffers, histamine, and a-smooth
muscle actin antibodies were purchased from Sigma (St.
Louis, MO, USA). The TRPC6 antibody was from Santa
Cruz (Dallas, TX, USA). Fura-2AM, Vectashield Antifade
Mounting Medium, and Carboxy SNARF-1 were from
Thermo Fisher Scientific.
Statistical analysis
All data are presented as mean ± standard error of the
mean (SEM). The unpaired t test was used to determine
whether there is a statistically significant difference
between the two data sets with normally distributed
populations and equal variances. The one-way ANOVA
test followed by the post hoc all pairwise multiple
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comparison Student–Newman–Keuls test was used to
determine whether there was a significant difference
between the means of multiple experimental groups with
normally distributed populations and equal variances. The
Kruskal–Wallis analysis of variance on ranks test fol-
lowed by the post hoc all pairwise multiple comparisons
Dunn’s test was used to compare the data sets with non-
normally distributed populations and unequal variances.
The two-way ANOVA test followed by the Student–
Newman–Keuls post hoc all pairwise multiple comparison
test was used to compare the experimental groups affected
by two different factors when the data sets were normally
distributed populations with equal variances. The Sig-
maPlot 13 software package (Systat Software Inc., San
Jose, CA, USA) was used to perform the statistical
analyses. The results were considered significantly dif-
ferent if the p value was\0.05.
Results
To investigate the effect of long-term spironolactone
treatment on TRPC expression and coronary pathology in
metabolic syndrome pigs, Ossabaw miniature pigs were
subdivided into three groups: Lean, metabolic syndrome
(MetS), and metabolic syndrome treated with spironolac-
tone (MetS-SN). All of the pigs were initially raised on the
standard chow to an age of about 6–8 months. The pigs
were then fed diets according to their group for an addi-
tional 7–9 months. The diets were as follows: the same
standard chow (Lean group), an atherogenic diet (1 kg/day,
MetS group), or the atherogenic diet supplemented with
spironolactone (3 mg/kg body weight/day, MetS-SN
group).
Metabolic phenotype
The pigs from the MetS and MetS-SN groups were obese
as compared to the Lean group with significantly greater
body weight (Table 1). However, there was no significant
difference between the average body weights in the MetS
and MetS-SN groups. MetS pigs exhibited elevated mean
systolic blood pressure, but it was not significantly differ-
ent from that observed in the MetS-SN group. The values
of mean diastolic blood pressure, serum sodium, serum
potassium, and serum triglycerides were not significantly
different among the tested groups (Table 1). Pigs from the
MetS and MetS-SN groups presented with impaired glu-
cose tolerance when compared to Lean pigs (Fig. 1a).
Blood glucose levels were higher in MetS and MetS-SN
pigs when compared with Lean pigs at the 5, 10, 20, and
30 min time points following a bolus of intravenous glu-
cose of 1 g/kg of body weight (Fig. 1a). The mean total
plasma cholesterol concentration was markedly elevated in
the MetS and MetS-SN groups as compared to that
observed in the Lean group (Lean: 69 ± 5 mg/dl, n = 12;
MetS: 613 ± 72 mg/dl, n = 10; MetS-SN: 385 ± 50 mg/
dl, n = 9; Fig. 1b). There was no difference between the
total plasma cholesterol concentrations observed in the
MetS and MetS-SN groups, indicating that spironolactone
treatment did not significantly affect the total plasma
cholesterol levels in the pigs.
Coronary artery disease
Collagen content is an important characteristic of
atherosclerotic plaques, as increased collagen deposits are
linked to coronary stenosis and increased plaque stability.
Therefore, we investigated whether collagen deposition in
the coronary artery medial layer and atheroma varied
among the experimental groups. The Masson’s trichrome
staining showed that collagen content was significantly
higher in the medial layer of MetS pigs (36.8 ± 3.5%,
n = 10) compared to Lean pigs (15.1 ± 1.8%, n = 6;
Fig. 1c–h; Supp. Figure 1). Long-term spironolactone
treatments significantly decreased total collagen deposition
in the medial layer (20.9 ± 3.2%, n = 6; MetS-SN group).
Atheroma collagen content was significantly decreased in
MetS-SN pigs compared to that in MetS pigs (Lean
atheroma 29.9 ± 10.3%, n = 3; MetS-SN atheroma
52.2 ± 13.3%, n = 4; MetS atheroma 77.5 ± 3.8%,
n = 6; Fig. 1h).
To obtain an initial assessment of the extent of
atherosclerosis in coronary arteries of Lean, MetS, and
MetS-SN groups, we first performed IVUS measurements
(Fig. 2). Lean coronary arteries presented only minimal
atherosclerosis (Fig. 2a, Lean). Conversely, MetS coronary
arteries exhibited increased atherosclerosis (Fig. 2a). The
percent wall coverage was significantly higher in coronary
arteries from left anterior descending (LAD) and right
coronary arteries (RCA) in MetS pigs compared to Lean
pigs (RCA: Lean 6.8 ± 1.1%, n = 4, MetS 37.4 ± 7.2%,
n = 7; LAD: Lean 5.7 ± 1.5%, n = 5, MetS
32.3 ± 6.4%, n = 7; Fig. 2b, c). Long-term spironolactone
treatment significantly reduced atherosclerosis in the LAD
MetS-SN group (the percent wall coverage: 16.1 ± 4.5%
for Met-SN LAD, n = 6, and 22.5 ± 5.8% for MetS-SN
RCA, n = 6; Fig. 2c). However, likely due to the limited
number of pigs examined with IVUS no significant dif-
ference was detected between the RCA-MetS and Met-SN
groups. However, histology to assess the degree of
atherosclerosis was performed on all pigs including those
MetS pigs that died during the study. The mean percent
wall coverage was significantly increased in MetS RCAs as
compared to that in Lean RCAs and significantly reduced
in MetS-SN RCAs as compared to the mean value
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observed in pigs from the MetS group (RCA-MetS:
60.2 ± 9%, n = 13; RCA-Lean: 13.1 ± 3.3%, n = 9; and
RCA-MetS-SN: 28.2 ± 7.3%, n = 9; Fig. 3). These data
indicate that long-term spironolactone treatment decreases
MetS-associated collagen deposition and the degree of
atherosclerosis.
MetS coronary arteries exhibit increased histamine-
induced contractions and intracellular Ca21
transients
Isometric tension measurements were performed to assess
the ex vivo contractility of coronary arteries from the three
tested groups. Coronary artery rings across the groups
exhibited similar concentration-dependent contraction
stimulated by KCl-mediated depolarization of smooth
muscles (Fig. 4a, b). The EC50 values were as follows:
Lean: 28 ± 2 mM; MetS: 29 ± 2 mM; MetS-SN:
33 ± 2 mM. Histamine (10-7 to 10-4 M) also induced
concentration-dependent contractions of coronary artery
rings from all of the three tested groups (Fig. 4c, d); and
contractions induced by 10, 30, and 100 lM histamine
were significantly increased in coronary arteries from MetS
pigs as compared to those from Lean and MetS-SN pigs
(for 10 lM—Lean: 1.05 ± 0.05, n = 13 vs. MetS
1.23 ± 0.1, n = 7; for 30 lM—Lean: 1.10 ± 0.07,
n = 13 vs. MetS: 1.65 ± 0.14, n = 7; MetS vs. MetS-SN:
1.3 ± 0.06, n = 9; for 100 lM—Lean: 1.26 ± 0.04,
n = 13 vs. MetS: 1.85 ± 0.15, n = 7; MetS vs. MetS-SN:
1.38 ± 0.06, n = 9). However, the EC50 values for his-
tamine (Lean 6.9 ± 1.1 lM; MetS 3.5 ± 0.6 lM; MetS-
SN 5.9 ± 1.5 lM; Fig. 4d) were not significantly different
among the tested groups.
We also employed front-surface fluorometry to assess
intracellular Ca2? ([Ca2?]i) changes in response to KCl and
histamine in fura-2 loaded rings (Fig. 5a). The peak
amplitudes of 70 mM KCl-stimulated Ca2? influx in Lean,
MetS, and MetS-SN groups did not differ significantly
(Lean 0.10 ± 0.02, n = 7; MetS 0.06 ± 0.01, n = 9;
MetS-SN 0.08 ± 0.02, n = 6). Conversely, the peak
amplitudes of 40 lM histamine-induced Ca2? influx were
significantly larger in MetS coronary artery rings
(1.1 ± 0.2, n = 9) than in Lean (0.4 ± 0.07, n = 7), and
MetS-SN (0.4 ± 0.1, n = 6; Fig. 5b–f). The mean steady
state values of histamine-induced [Ca2?]i increases were
greater in MetS rings (0.56 ± 0.10, n = 6) than in Lean
rings (0.15 ± 0.03, n = 4) and MetS-SN rings
(0.18 ± 0.03, n = 5; Fig. 5b–f). These data indicate that
besides reducing atheroma formation, long-term spirono-
lactone treatments attenuate histamine-induced [Ca2?]i
changes and vasoconstriction that is associated with MetS.
MetS-associated coronary artery endothelial
dysfunction can be prevented by long-term
treatment with spironolactone
MetS coronary arteries are known to exhibit endothelial
dysfunction. Indeed, Fig. 6a shows that concentration-de-
pendent bradykinin-induced dilations were significantly
decreased in MetS pig coronary arteries pre-contracted
with 100 lM histamine (n = 10) as compared to those
from Lean pigs (n = 7). Long-term treatment with
spironolactone significantly improved endothelial function
in MetS pig coronary arteries pre-contracted with 100 lM
histamine (n = 6, Fig. 6a). Figure 6b shows that similar
results were obtained in 30 mM KCl pre-contracted coro-
nary artery rings (MetS, n = 5; Lean, n = 8, and MetS,
n = 5). MetS coronary artery rings presented with mark-
edly impaired bradykinin-induced dilations as compared to
30 mM KCl pre-contracted Lean pig coronary artery rings,
and spironolactone-treated MetS-SN pigs showed signifi-
cantly improved bradykinin-induced dilations.
Table 1 Phenotypic characteristics of pig groups
Lean MetS MetS-SN P values
L vs. MetS L vs. MetS-SN MetS vs. MetS-SN
Number of animals 7 7 6
Body weight (kg) 49 ± 4 84 ± 3 79 ± 3 \0.001 \0.001 0.3
SBP (mmHg) 131 ± 3 151 ± 3 138 ± 7 0.01 0.27 0.06
DBP (mmHg) 75 ± 4 84 ± 4 71 ± 4 NS NS NS
Triglycerides (mg/dl) 28.9 ± 6.3 41.7 ± 13.0 30.7 ± 3.3 NS NS NS
Sodium (mEq/l) 136.3 ± 1.0 139.4 ± 0.7 138.2 ± 1.2 NS NS NS
Potassium (mEq/l) 4.9 ± 0.7 4.4 ± 0.3 4.3 ± 0.2 NS NS NS
The one-way ANOVA test followed by the Student–Newman–Keuls post hoc test
L lean, MetS metabolic syndrome, MetS-SN metabolic syndrome group treated with spironolactone, SBP and DBP systolic and diastolic blood
pressure, NS no significant different
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Pattern of TRPC immunostaining in the coronary
artery wall
To determine whether the MetS-associated increases in
TRPC1 and TRPC6 protein expression occur locally or
globally within the coronary wall immunohistochemical
studies were performed. TRPC1 immunostaining was weak
in the medial layer of all tested groups (Fig. 7a). The mean
immunostaining density ratios of adventitia over media
were as follows: 1.08 ± 0.03 (n = 4), 1.10 ± 0.02 (n = 9)
and 1.06 ± 0.02 (n = 5), for Lean, MetS, and MetS-SN
groups, respectively (Fig. 7b). Conversely, TRPC1
immunostaining was significantly greater in MetS athero-
mas than in MetS medial layer (MetS atheroma:
1.77 ± 0.23, n = 7). Spironolactone treatment signifi-
cantly decreased TRPC1 immunostaining in the atheromas
(MetS-SN atheroma 1.11 ± 0.12, n = 5, Fig. 7b). These
data indicate that in Lean pigs, TRPC1 expression is low in
the coronary artery wall with a particular localization to the
medial layer. The channel’s protein expression is not
Fig. 1 Metabolic phenotype
and coronary wall collagen
content in Lean, MetS, and
MetS-SN pigs. a, Time course
of changes in blood glucose
concentration obtained during
intravascular glucose tolerance
test. MetS or MetS-SN pigs
IVGTTs are compared to that in
Lean pigs (n = 5–8 pigs at each
data point). *P\ 0.05 (MetS
vs. Lean); P\ 0.05 (MetS-SN
vs. Lean); ***P\ 0.001; 
P\ 0.001; the two-way
ANOVA test followed by the
post hoc Student–Newman–
Keuls test. b Summary for mean
total plasma cholesterol
concentrations determined in
samples from the three
experimental groups.
*P\ 0.05; Kruskal–Wallis one-
way analysis of variance on
ranks followed by the Dunn’s
post hoc test; c–g Masson’s
trichrome staining of coronary
artery wall sections. Both non-
atherosclerotic coronary artery
sections (c, e) and
atherosclerotic coronary artery
sections (d, f) are shown in the
MetS and MetS-SN groups.
Collagen is stained blue and
smooth muscles are stained red.
Bars 100 lm. A adventitia,
M medial layer, I intima,
L lumen, magnification 920.
h Quantification of collagen
percent area in the media layer
and the atherosclerotic lesions.
*P\ 0.05; **P\ 0.01;
***P\ 0.001; P\ 0.05; NS
non-significant. The two-way
aNOVA test followed by the
Student–Newman–Keuls post
hoc test
54 Page 8 of 20 Basic Res Cardiol (2017) 112:54
123
significantly increased in the medial layer of MetS pigs.
However, TRPC1 is highly expressed in the atheromas of
MetS pigs.
In the coronary artery wall, TRPC6 immunostaining was
localized to the medial layer in all the tested groups. Its
density was similarly low in both adventitia and atheroma
of MetS and MetS-SN pigs (MetS: 1.02 ± 0.06, n = 6;
MetS-SN: 1.10 ± 0.07, n = 4, Fig. 7c). But, TRPC6
immunostaining density was much stronger in the medial
layer of MetS pigs as compared to that in the Lean and
MetS-SN medial layers, with the TRPC6 staining ratios of
adventitia/medial being as follows: Lean 1.13 ± 0.08
(n = 6) vs. MetS 1.56 ± 0.09 (n = 9), and MetS vs. MetS-
SN 1.19 ± 0.11 (n = 6). These data indicate that TRPC6
expression is increased in the medial layer, but not in
atheromas of MetS coronary artery wall; and that TRPC6
upregulation in the MetS medial layer is diminished by
spironolactone treatment (Suppl. Figure 2).
Fig. 2 Intravascular ultrasound (IVUS) assessment of atherosclerosis
in Lean, MetS, and MetS-SN pigs. a Sample IVUS cross-sectional
images of coronary arteries are shown. The external elastic membrane
border and actual lumen border are indicated with red and yellow
lines, respectively. 1 Coronary artery lumen. 2 The angioplasty
guidewire artifact. b Scatter plots of the percent wall coverage along
the RCA and LAD of each pig of three groups coded with different
symbols and colors (Lean = red; MetS = blue; and MetS-
SN = green) determined using IVUS. c Comparison of average wall
coverage determined using IVUS in Lean (red), MetS (blue) and
MetS-SN (green) groups. *P\ 0.05; **P\ 0.01. The two-way
ANOVA test followed by the Student–Newman–Keuls post hoc test
Fig. 3 Atherosclerosis assessment using histology. a, Sample images
of H&E staining of coronary artery sections from the three tested
groups. b Summary of histological evaluation of atheroma percent
wall coverage in cross sections of RCAs from Lean, MetS and MetS-
SN groups. **P\ 0.01; ***P\ 0.001. The one-way ANOVA test
followed by the Student–Newman–Keuls post hoc test
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Increased TRPC expression correlates
with coronary artery pathology
To determine whether there is an association between
increased TRPC expression and coronary artery pathology,
we performed the Pearson Product Moment Correlation
analysis (SigmaPlot 13). TRPC6 expression and histamine-
induced active tension (Fig. 4) as well as TRPC1 expres-
sion and atherosclerosis associations (Fig. 3) were ana-
lyzed. We found that the Pearson Product Moment
correlation coefficients amounted to 0.78 and 0.86 for the
TRPC6-active tension data sets and the TRPC1-percent
wall coverage data sets, respectively, indicating a strong
correlation between these pairs of variables (Fig. 8).
TRPC1 immunostaining is predominantly found
in macrophage-rich atheroma areas
The fact that the strongest TRPC1 immunostaining was
observed in atheromas rather than in the medial layer
prompted us to hypothesize that TRPC1 expression may be
localized to the proliferating SMCs in atheromas. To test
this hypothesis, SMCs in the adjacent MetS sections were
stained with an a-smooth muscle actin (SMA) antibody.
Unexpectedly, we found that although TRPC1 immunos-
taining was present in some neointimal SMCs of athero-
mas, it was stronger in the plaque areas having less SMA
immunoreactivity (Fig. 9; Suppl. Figure 3). Therefore, we
next stained the adjacent sections of coronary arteries from
MetS pigs for markers of macrophages (CD163 and CD33)
and T cells (CD3) and compared staining patterns with that
of TRPC1. It was noticeable that TRPC1 staining was
predominantly observed in the segments of atheromas with
robust CD163 and CD33 immunostaining, and scant CD3
immunostaining (Fig. 9a; Suppl. Figure 3), indicating
atheroma’s TRPC1 immunostaining is not only found in
neointimal SMCs but also strongly associated with mac-
rophages. Figure 9b shows the phenotyping of atheroscle-
rotic lesions. The mean % content of a-SMA, CD163,
CD33, and CD3 immunoreactivities amounted to
37.5 ± 5.6, 58.8 ± 11.6, 45.7 ± 6.7, and 9.4 ± 3.4%,
respectively (n = 6, in each case).
In vivo dominant-negative TRPC6 cDNA construct
delivery
The correlation between TRPC6 expression and histamine-
induced coronary contractions prompted us to investigate
whether decreasing coronary TRPC6 activity would reduce
histamine-induced [Ca2?]i transients in MetS pig coronary
arteries. In vivo gene transfer of the dominant-negative
(DN) TRPC6 construct was performed into coronary artery
walls in beating hearts. Figure 10a shows sample angio-
graphic images obtained during the intracoronary
Fig. 4 Isometric tension
measurements. a, c Sample
traces of active tension changes
induced by KCl or histamine in
coronary artery rings from the
Lean group are shown.
Contractions were induced by
cumulatively increasing
concentrations of KCl
(10–70 mM, a) or histamine
(10-7 to 10-4 M, c). b,
d Concentration–response
curves for KCl and histamine.
His histamine. The mean active
tension value for each data point
was calculated by averaging the
mean active tension values
obtained from 2 to 4 rings in
each pig. *P\ 0.05;
***P\ 0.001; for MetS vs.
Lean and #P\ 0.05; ##P\ 0.01
for MetS vs. MetS-SN. The two-
way ANOVA test followed by
the Student–Newman–Keuls
post hoc test
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placement of the injection and electroporation catheters
inside of a circumflex coronary artery in vivo (see ‘‘Ma-
terials and methods’’ for details). We found that electro-
porated coronary arteries were fragile (Fig. 10b),
complicating isometric tension experiments with the elec-
troporated rings. Therefore, we focused on fluorescence
imaging to compare the peak amplitudes of histamine-
induced [Ca2?]i transients in the in vivo injected/electro-
porated and control rings adjacent to the electroporated
area, which were isolated from the same pig. [Ca2?]i
transients are critical for triggering coronary smooth mus-
cle cell contractions. In control experiments, the Lean pig
coronary artery rings that were in vivo injected with
pcDNA3 empty vector and then intracoronary
Fig. 5 Front-surface fluorometry in coronary artery rings loaded with
Fura-2. a Fluorescence images of a coronary artery ring from a Lean
pig, which were obtained at an excitation wavelength of 380 nM (left
panel control; middle panel under 70 mM KCl; right panel under
40 lM histamine). b–d Sample traces of [Ca2?]i changes in coronary
artery rings from Lean (a), MetS (b), and MetS-SN (c) rings are
shown. KCl and histamine (40 lM) were added at the times indicated
with the horizontal bars. e Summary of data for the peak (blue
vertical line in b–d) values of [Ca2?]i responses to histamine (40 lM)
normalized to the peak of KCl response in the tested rings. *P\ 0.05;
**P\ 0.01. The one-way ANOVA test followed by the Student–
Newman–Keuls post hoc test. f Steady state phase (red vertical line in
b–d) values of [Ca2?]i responses to histamine (40 lM) normalized to
the peak of KCl response in the tested rings. The steady state value
was calculated at 3.3 min after the peak value of the histamine
response was reached. Kruskal–Wallis one-way analysis of variance
on ranks followed by the Dunn’s post hoc test. *P\ 0.05;
**P\ 0.01. His histamine
Fig. 6 Assessment of endothelial function in coronary arteries from
the three tested groups using isometric tension measurements. a,
b Concentration–response curves for bradykinin-induced dilation in
histamine- (a) and 30 mM KCl- (b) pre-contract coronary artery rings
from Lean, MetS and MetS-SN pigs. Sample traces of bradykinin-
induced coronary ring dilations are shown in insets. *P\ 0.05,
**P\ 0.01, ***P\ 0.001, *MetS vs. Lean; #P\ 0.05, ##P\ 0.01,
###P\ 0.001, #MetS vs. MetS-SN. The two-way ANOVA test
followed by the Student–Newman–Keuls post hoc test
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electroporated exhibited normalized histamine-induced
[Ca2?]i transients that were not significantly different from
those observed in non-electroporated rings (Fig. 10c, e).
While the empty vector had no effect, we confirmed that
there was no non-specific effect of the electroporation and
instrumentation by over expressing another histamine-
regulated channel, TRPC5. The Lean pig coronary artery
rings in vivo injected/electroporated with mTRPC5-
pcDNA3 exhibited significantly greater normalized his-
tamine-induced [Ca2?]i transients compared to those
observed in pcDNA3-injected/electroporated rings
(Fig. 10c, e). Gd3? (100 lM) caused only small or no
inhibition of histamine-induced [Ca2?]i transients in the
tested rings (Fig. 10c), likely due to poor permeability of pig
coronary artery wall to Gd3?. Importantly, we found that
normalized histamine-induced [Ca2?]i transients were sig-
nificantly decreased in MetS pig coronary artery rings
in vivo injected/electroporated with a dominant-negative
(DN) TRPC6 construct as compared to those observed in
control rings (Fig. 10d, e).
Fig. 7 Assessment of TRPC expression pattern in the coronary artery
wall. a Sample images of immunohistochemical staining of coronary
artery ring sections from the tested groups. The upper row of images
shows controls in which no primary antibody (AB) was added. The
middle row of images show the sections stained with the TRPC1
antibody, whereas the lower row of images shows the sections stained
with the TRPC6 antibodies. The medial layer is indicated with black
arrows in TRPC1 images and white arrows in the TRPC6 images.
The dotted lines show the borders between the coronary wall layers.
Scale bars 100 lm. A adventitia, M media, I intima, L lumen. b,
c Comparison of mean normalized density of immunostaining in the
tested groups for TRPC1 and TRPC6, respectively. *P\ 0.05;
**P\ 0.01. The two-way ANOVA test followed by the Student–
Newman–Keuls post hoc test
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Aldosterone treatment increases histamine-induced
contractions of organ-cultured coronary arteries
in a mineralocorticoid receptor-dependent manner
We previously reported that TRPC6 expression was
upregulated in coronary arteries of MetS pigs [16]; and that
plasma aldosterone was elevated in MetS Ossabaw pigs
[2]. It was also reported that that aldosterone treatment
leads to increased TRPC6 expression in arterial smooth
muscle cells [3]. To provide further evidence supporting
the hypothesis that TRPC6 upregulation correlates with
increased pig coronary artery contractility, we next
employed the in vitro organ-culture model. Using quanti-
tative RT-PCR, we confirmed that aldosterone treatment
increased TRPC6 expression in organ-cultured Lean pig
coronary artery rings (Suppl. Figure 4). Then, we assessed
whether aldosterone treatment would increase coronary
contractility, and whether inhibition of the mineralocorti-
coid receptor by spironolactone would prevent this effect.
Four groups of Lean coronary artery rings were initiated as
follows: (1) DMSO (vehicle control) group; (2) aldosterone
(100 nM) group; (3) aldosterone (100 nM) plus spirono-
lactone (10 lM) group; and (4) spironolactone (10 lM)
group. The rings (3 mm long) were organ-cultured for
7 days without fetal bovine serum to avoid any possible
contribution of growth factors and other vasoactive mole-
cules present in the fetal bovine serum; and the histamine-
induced contractility of the rings was measured using a
wire myograph. Figure 11 shows that the contractions
induced by 10, 100, 300, and 1000 lM histamine were
significantly stronger in both intact (Fig. 11a, n = 7) and
denuded (Fig. 11b, n = 6) rings treated with aldosterone as
compared to those treated with DMSO and spironolactone.
Aldosterone-induced increases in coronary contractility
were comparable in both denuded and intact rings, arguing
against any role of the endothelium in mediating the
aldosterone-induced contractility changes. Importantly, the
‘‘aldosterone plus spironolactone’’-treated rings exhibited
contraction amplitudes similar to those observed in the
DMSO-treated and spironolactone-treated groups, but sig-
nificantly smaller than those found in the aldosterone-
treated group. These data indicate that inhibition of the
mineralocorticoid receptor by spironolactone prevents
aldosterone-dependent upregulation of histamine-induced
coronary contractility.
Monocytes adhesion to the endothelium is regulated
by aldosterone in a mineralocorticoid receptor-
dependent manner
The adhesion of monocytes to the endothelium of coro-
nary arteries and their subsequent extravasation constitute
the earliest steps of atherosclerosis progression. To
investigate the role of aldosterone in regulating monocyte
adhesion to the endothelium of Lean pig coronary arter-
ies, we again used the organ-cultured coronary arteries.
Again, four test groups were initiated and treated for 48 h
with (1) DMSO; (2) aldosterone; (3) aldosterone plus
spironolactone; and (4) spironolactone. Coronary artery
strips were used in these experiments. Peripheral blood
monocytes were isolated using flow cytometry. Fig-
ure 12a shows that the degree of monocyte enrichment
exceeded 75%, about five times higher than the initial
monocyte count (16.1%). The pig monocytes exhibited
low levels of adhesion to the endothelium of DMSO and
spironolactone-treated coronary arteries. Only a few
adherent cells were observed in these experiments
(Fig. 12b). Conversely, aldosterone treatment increased
monocytes adhesion to coronary artery strips by 2.4 ± 0.6
fold. Spironolactone treatment potently inhibited aldos-
terone-mediated monocyte adhesion to the coronary
endothelium (Fig. 12c).
Fig. 8 Pearson correlation analysis. a, b The correlation plots show
strong correlations between: a TRPC6 expression and active tension
induced by 100 lM His normalized to 70 mM KCl as shown in
Figs. 4 and 7; and b TRPC1 expression and percentage wall coverage
from Figs. 3 and 7. The linear regression lines were drawn through all
points of the graphs
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TRPC1 is expressed in macrophages differentiated
from pig peripheral blood monocytes
We next investigated whether the expression level of
TRPC1 is distinct in differentiated macrophages obtained
from the Lean, MetS, and MetS-SN groups. Pig peripheral
blood mononuclear cells were isolated and differentiated
into macrophages by culturing in the presence of the L929
conditioned medium. TRPC1 mRNA expression was
quantified in the differentiated macrophages. TRPC1 was
equally expressed in the macrophages across the tested
groups (Suppl. Figure 5).
Fig. 9 Immunostaining of
MetS coronary artery sections
from three representative MetS
pigs. a The sections were
stained with the TRPC1, a-
smooth muscle actin (SMA),
CD163, CD33, or CD3
antibodies. Scale bars 500 lm.
The ‘‘MetS-TRPC1 antibody’’
image in Suppl. Figure 2 is
identical to the image of ‘‘MetS
Pig 2-TRPC1’’ in a. b Percent
contents of a-smooth muscle
actin (SMA), CD163, CD33, or
CD3 in atherosclerotic lesions
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Discussion
In this study, we investigated the roles of TRPC channels in
MetS coronary arteries and determined whether spirono-
lactone exhibits any anti-atherosclerotic potential in the
Ossabaw pig model of diet-induced metabolic syndrome.
Our principal new findings include: (1) TRPC1 is highly
expressed in the macrophages residing in the atheroma of
metabolic syndrome coronary arteries; (2) elevated TRPC6
is mostly found in the contractile coronary SMCs of the
medial layer but not in proliferative neointimal SMCs or
macrophages of atheroma; (3) histamine-induced [Ca2?]i
Fig. 10 In vivo electroporation in Lean and MetS pigs. a X-ray
angiographic images demonstrating the steps of in vivo electropora-
tion procedure in pig coronary arteries. Left image a MetS coronary
artery tree (red arrow) was visualized using the contrast reagent
injected via the guiding catheter. Middle image the placement of the
injection catheter into the circumflex artery of the same pig. The green
arrow shows the guiding catheter. The blue arrow shows the injection
microneedle. The orange arrows show the two radio-opaque markers.
The white circle shows the approximate position of the injection
catheter. Right image the placement of the electroporation catheter in
the same pig artery. The green arrow shows the guiding catheter. The
white arrow shows the proximal and distal electrodes. The yellow
arrows show the central electrode. The white circle shows an
approximate position of the electroporation catheter. b Fluorescence
images of a Lean coronary artery ring from an in vivo injected and then
electroporated pig, which were obtained at an excitation wavelength of
380 nm (left panel control; middle panel under 70 mM KCl; right
panel under 40 lM histamine; Lean-mTRPC5). c, d Sample traces of
70 mM KCl and 40 lM histamine-induced [Ca2?]i changes in
coronary artery rings (c mTRPC5; d DN-TRPC6). e Summary data
are shown for the tested rings (Lean 1, n = 11; Lean-pcDNA3, n = 4;
Lean 2, n = 6; Lean-mTRPC5, n = 6; MetS, n = 7; MetS-DN-
TRPC6, n = 6). The peak amplitudes of [Ca2?]i changes in the
presence of histamine (40 lM) are normalized to KCl (70 mM).
pcDNA3 the empty vector, mTRPC5 mouse TRPC5, DN-TRPC6
dominant-negative TRPC6. *P\ 0.05; **P\ 0.01. The unpaired
t test was used to determine whether there is a statistically significant
difference between the indicated two data sets
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transients are significantly decreased in the MetS coronary
artery segments after in vivo targeted DN-TRPC6 delivery;
and (4) long-term spironolactone treatment significantly
decreases the protein expression level of TRPC1 and
TRPC6 channels in coronary arteries associated with
reduced native atherosclerosis and vasoconstriction.
Upregulation of TRPC1 expression in neointimal SMCs
is critical for occlusive coronary artery disease progression
in the pig model of neointimal hyperplasia after vascular
injury via balloon angioplasty [33]. Surprisingly, we found
that in contrast to the vascular injury model, the diet-in-
duced pig model of MetS-associated atherosclerosis
showed that the TRPC1 protein is predominantly expressed
in macrophages residing in the cores of atheromas (Suppl.
Figure 3), although TRPC1 immunostaining is also
observed in some neointimal SMCs. Thus, our data
underscore the importance of macrophage TRPC1 expres-
sion in coronary atherosclerosis in MetS.
Unlike TRPC1, TRPC6 expression was greater in the
medial layer of MetS coronary arteries. Both histamine-
induced contractions and [Ca2?]i transients are increased in
coronary arteries from the MetS group that exhibited an
increased TRPC6 protein level in the medial layer. These
data support our overall hypothesis that higher TRPC6
expression in the smooth muscle layer correlates with
increased coronary contractility.
Coronary arteries from spironolactone-treated MetS pigs
exhibited milder atherosclerosis and reduced collagen
content and spasticity compared to age-matched control
MetS coronary arteries did. Thus, our findings provide
evidence that spironolactone attenuates MetS-associated
coronary atherosclerosis. These data are consistent with
two previous reports indicating that another
mineralocorticoid receptor inhibitor, eplerenone, and
aldosterone synthase inhibitors are effective at slowing
plaque growth in a mouse ApoE-/- model of aortic
atherosclerosis [20, 31] and a recent initial clinical study
reporting that spironolactone may decrease atherosclerosis
in humans [37]. Importantly, in this study, we utilized the
diet-induced pig model of MetS-associated coronary
atherosclerosis, which better represents the human setting
than the mouse ApoE knock-out/cholesterol handling-de-
pendent model of atherosclerosis [34].
Previously, we reported that TRPC1 and TRPC6
expression is markedly elevated in metabolic syndrome pig
coronary arteries [16]. The promoter regions of TRPC1 and
TRPC6 possess half-site glucocorticoid/mineralocorticoid
response elements [26] driving the expression of these
TRPC channels in metabolic syndrome, characterized by
elevated plasma aldosterone [2]. Our new data indicate that
one of the mechanisms underlying spironolactone’s bene-
ficial actions in atherosclerosis may include decreased
TRPC channel expression in the coronary artery wall.
Specifically, spironolactone-dependent reduction of
TRPC1 in atheroma was strongly associated with a marked
decrease of atherosclerosis, whereas spironolactone-de-
pendent downregulation of medial TRPC6 was associated
with decreased histamine-induced contractility and reduced
[Ca2?]i transients in the medial layer. Consistently, we
found that in vivo targeted delivery of the DN-TRPC6
construct into the MetS coronary artery wall using an
in vivo intracoronary electroporation approach resulted in
decreased histamine-induced [Ca2?]i transients in the MetS
coronary artery segments. Collectively, this supports the
hypothesis that TRPC6 upregulation leads to increased
coronary contractility. However, the limitation of this study
Fig. 11 Effect of aldosterone and spironolactone treatment on organ-
cultured coronary arteries. e, f Concentration–response curves for
histamine in intact (a, n = 7) and denuded (b, n = 6) organ-cultured
rings treated with DMSO, aldosterone, aldosterone plus spironolac-
tone, or spironolactone for seven days (*Ald vs. DMSO; #Ald vs.
Ald ? SN; Ald vs. SN). Sample traces are shown in insets.
*P\ 0.05, **P\ 0.01, P\ 0.05, P\ 0.01, P\ 0.001,
#P\ 0.05, ##P\ 0.01. The two-way ANOVA test followed by the
Student–Newman–Keuls post hoc test
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is that coronary artery reactivity is assessed only using the
in vitro approaches in coronary artery rings. Although these
coronary artery ring data were important for establishing
the critical correlation between TRPC6 expression and
coronary artery contractility in diet-induced metabolic
syndrome, future experiments will be needed to confirm the
present in vitro reactivity results using the in vivo coronary
histaminergic provocation test.
Macrophage accumulation in the coronary intima plays
a critical role during atherosclerotic plaque formation and
growth [14, 30]. However, the mechanism of how macro-
phage TRPC1 expression promotes coronary atheroscle-
rosis progression remains unclear. We found that TRPC1
and macrophage immunostaining were pronounced in
MetS atheromas and reduced in MetS-SN atheromas. Since
elevated aldosterone is a feature of metabolic syndrome,
we hypothesized that higher TRPC1 immunostaining in
MetS atheromas may be due to an aldosterone-dependent
increase in monocyte adhesion to the coronary endothelium
and that spironolactone may decrease monocyte adhesion.
Indeed, it was reported that endothelial intercellular adhe-
sion molecule (ICAM1) gene and protein expression was
upregulated in human coronary artery endothelial cells by
aldosterone in a mineralocorticoid receptor-dependent
manner [7], leading to increased adhesion of leukocytes.
To test our hypothesis, we used the organ-cultured coro-
nary artery rings from Lean pigs. We treated the organ-
cultured rings with aldosterone and found that aldosterone
did increase adhesion of monocytes to pig coronary artery
endothelium (Fig. 12). Importantly, spironolactone antag-
onized this effect. Therefore, we speculate that spirono-
lactone may slow down atherosclerosis progression by
reducing TRPC1-positive monocyte adhesion to the coro-
nary endothelium and their subsequent extravasation.
Spironolactone inhibits microsomal cholesterol 7a-hy-
droxylase activity and increases bile salt-independent bile
flow (choleresis) in the liver, resulting in increased
cholesterol excretion into the bile [42]. However, subse-
quent clinical studies revealed controversial findings, indi-
cating that spironolactone may or may not affect total
cholesterol level in human subjects [9, 17, 39, 48]. Elevated
levels of plasma cholesterol are strongly associated with
atherosclerosis development [4]. Therefore, we investigated
spironolactone’s effect on total plasma cholesterol level in
the Ossabaw pig model. Our data indicate that spironolac-
tone does not significantly reduce plasma cholesterol con-
centration in the Ossabaw pig model of MetS. Therefore, we
propose that the observed effects of spironolactone in our
study are unlikely to be due to a reduction of total plasma
cholesterol concentration in the MetS-SN pigs.
Fig. 12 Monocytes adhesion assay. a Representative images show
flow cytometry sorts of peripheral blood mononuclear cells before and
after monocyte enrichment. The cells were stained with pig CD3 and
CD172a antibodies. Images show a marked increase in monocyte
populations and T-cell depletion. b Images of monocytes adhesion to
the endothelium after an incubation for 2 h with coronary artery strips
pretreated with DMSO, aldosterone (Ald), aldosterone plus spirono-
lactone (Ald ? SN) and spironolactone (SN) for 48 h. The monocytes
were loaded with the dye of SNARF-1 and seen as red spots. Bar
200 lm. c Summary for data shown in b. **P\ 0.01. The one-way
repeated measures ANOVA test followed by the Holm–Sidak post
hoc test
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Long-term spironolactone treatment in MetS pigs pre-
vents MetS-associated endothelial dysfunction. These data
are consistent with a recent report that eplerenone, another
antagonist of the mineralocorticoid receptor, prevented
endothelial dysfunction associated with diet-induced obe-
sity in C57BL/6 mice [44]. Schafer et al. [44] provided
evidence that eplerenone-mediated inhibition of endothe-
lial mineralocorticoid receptors results in a reduction of
pro-oxidative p22phox and p40phox gene expression and
an increase in expression of antioxidative genes, such as
glutathione peroxidase-1 and superoxide dismutase, coun-
teracting aldosterone-dependent reactive oxygen species
generation in endothelial cells. We speculate that a similar
mechanism may underlie spironolactone’s effects in our
pig model of metabolic syndrome.
The major physiological function of aldosterone in the
human body is to regulate Na? and K? plasma concen-
trations. Aldosterone acting via the mineralocorticoid
receptor in the principal epithelial cells of the kidney col-
lecting duct causes Na? retention, which is important for
regulating blood volume. However, excessive aldosterone-
dependent Na? retention results in hypertension. Spirono-
lactone, a competitive inhibitor of the mineralocorticoid
receptors, is widely prescribed to treat hypertension due to
the abnormal Na? retention by the kidney. In this study, we
did find that the mean systolic blood pressure was elevated
in the MetS pigs. However, the mean systolic blood pres-
sure in MetS-SN pigs was not significantly different from
its mean value in MetS pigs. Given the fact that neither
blood pressure nor plasma Na? concentration was signifi-
cantly different in MetS and MetS-SN groups (Table 1),
these data argue against the notion that spironolactone
action on the kidney underlies the anti-atherosclerotic
effect of this drug. We propose that mineralocorticoid
receptor antagonism by spironolactone in the coronary
artery wall rather than in the kidney contributes to the
improvements observed in the MetS-SN group.
The combined reduction in arterial pressure and plasma
cholesterol, although both not statistically significant, may
synergize to attenuate atheroma. We contend, however,
that this combination of systemic factors is unlikely to be
the underlying cause for the reduced lesion size. We pro-
pose that the direct vascular wall signaling plays the major
role in atheroma reduction.
Conclusions
This study demonstrates that long-term mineralocorticoid
receptor blockade with spironolactone decreased coronary
TRPC expression, atherosclerosis, and hypercontractility in
the Ossabaw pig model of metabolic syndrome without
impacting obesity or glucose tolerance. Targeted down-
regulation of TRPC6 by intracoronary application of a
dominant-negative construct provides additional evidence
for the key role of TRPC6 in hypercontractility of MetS
coronary arteries. TRPC1-positive macrophages present in
the coronary artery wall of MetS pigs are associated with
advanced atherosclerotic lesions.
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